NO960550L - Metode for forhindring av nöytrofilformidlet bindevevsskade - Google Patents

Metode for forhindring av nöytrofilformidlet bindevevsskade

Info

Publication number
NO960550L
NO960550L NO960550A NO960550A NO960550L NO 960550 L NO960550 L NO 960550L NO 960550 A NO960550 A NO 960550A NO 960550 A NO960550 A NO 960550A NO 960550 L NO960550 L NO 960550L
Authority
NO
Norway
Prior art keywords
connective tissue
tissue damage
neutrophil mediated
preventing neutrophil
mediated connective
Prior art date
Application number
NO960550A
Other languages
English (en)
Other versions
NO960550D0 (no
Inventor
Michael John Janusz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO960550L publication Critical patent/NO960550L/no
Publication of NO960550D0 publication Critical patent/NO960550D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Oligomerer av formel (I) (D har utvist effektivitet ved forhindring av bindevevsskade.
NO960550A 1993-08-12 1996-02-12 Metode for forhindring av nöytrofilformidlet bindevevsskade NO960550D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10555793A 1993-08-12 1993-08-12
PCT/US1994/007696 WO1995005185A1 (en) 1993-08-12 1994-07-11 Method of preventing neutrophil mediated connective tissue damage

Publications (2)

Publication Number Publication Date
NO960550L true NO960550L (no) 1996-02-12
NO960550D0 NO960550D0 (no) 1996-02-12

Family

ID=22306496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960550A NO960550D0 (no) 1993-08-12 1996-02-12 Metode for forhindring av nöytrofilformidlet bindevevsskade

Country Status (13)

Country Link
US (1) US5384119A (no)
EP (1) EP0713394A1 (no)
JP (1) JPH09500903A (no)
KR (1) KR960703608A (no)
CN (1) CN1128952A (no)
AU (1) AU680284B2 (no)
CA (1) CA2168211A1 (no)
HU (1) HUT74581A (no)
IL (1) IL110616A0 (no)
NO (1) NO960550D0 (no)
TW (1) TW285641B (no)
WO (1) WO1995005185A1 (no)
ZA (1) ZA945938B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
DE1067212B (de) * 1956-06-04 1959-10-15 Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk Verfahren zur Herstellung von löslichen Polyharnstoffen
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
DE2162963C3 (de) * 1971-12-18 1979-02-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 1,4-Diaminobenzol-2,5-disulfonsäure
US3993625A (en) * 1973-05-28 1976-11-23 Toray Industries, Inc. Permselective polymeric membranes of organic polyamide or polyhydrazide
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
DE2516305A1 (de) * 1975-04-15 1976-10-28 Dynamit Nobel Ag Wasserdispergierbare esterharze
US4087548A (en) * 1976-05-10 1978-05-02 American Cyanamid Company Complement inhibitors
US4027038A (en) * 1976-05-10 1977-05-31 American Cyanamid Company Complement inhibitors
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
WO1980000151A1 (en) * 1978-07-03 1980-02-07 American Home Prod N-(3-alkylaminopropyl)-n'-phenylureas
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4724235A (en) * 1981-05-20 1988-02-09 A. H. Robins Company, Incorporated N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
DE3345902A1 (de) * 1983-12-20 1985-08-29 Cassella Ag, 6000 Frankfurt In wasser loesliche polymischester, verfahren zu ihrer herstellung und ihre verwendung
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
GB9014546D0 (en) * 1990-06-29 1990-08-22 Fujisawa Pharmaceutical Co Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
KR960703608A (ko) 1996-08-31
HU9600305D0 (en) 1996-04-29
AU680284B2 (en) 1997-07-24
CA2168211A1 (en) 1995-02-23
ZA945938B (en) 1995-03-16
US5384119A (en) 1995-01-24
EP0713394A1 (en) 1996-05-29
HUT74581A (en) 1997-01-28
AU7358694A (en) 1995-03-14
JPH09500903A (ja) 1997-01-28
CN1128952A (zh) 1996-08-14
TW285641B (no) 1996-09-11
WO1995005185A1 (en) 1995-02-23
IL110616A0 (en) 1994-11-11
NO960550D0 (no) 1996-02-12

Similar Documents

Publication Publication Date Title
FI952926A (fi) Menetelmät allergioiden hoitamiseksi tai ehkäisemiseksi
PL343495A1 (en) Heterocyclically substituted amides used as calpain inhibitors
WO1996003374A1 (en) Thrombin inhibitors
CA2155931A1 (en) Inhibitors of thrombosis
IT1295535B1 (it) Processo di polimerizzazione di vinilidenfluoruro (vdf)
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
DE69300043D1 (de) Substituierte Pipecoline-Säurederivate als HIV-Protease-Hemmer.
ITMI950589V0 (it) Apparecchiatura di sterilizzazione al plasma
DE69434511D1 (de) Botulinumtoxin zur Behandlung von Dystonie
NO983688L (no) Serin-protease-inhibitorer
ES2172657T3 (es) Inhibidores de trombina.
MY121222A (en) Prodrugs of thrombin inhibitors
DE69709727D1 (de) Parazinon thrombin inhibitoren
WO1999005096A3 (en) Urokinase inhibitors
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
SE9602263D0 (sv) New amino acid derivatives
ATE261969T1 (de) Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
EP0587799A4 (en) CATHEPSIN G AND ELASTASE INHIBITORS PREVENTING DEGRADATION OF CONNECTIVE TISSUE.
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
NO980643L (no) Propylendopeptidase inhibitorer
NO960550L (no) Metode for forhindring av nöytrofilformidlet bindevevsskade
ES2186807T3 (es) Inhibidores de trombina.
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
DE69604719D1 (de) Entfernung von Oligomeren aus im wesentlichen kristallinen Alpha-Olefinpolymeren
AU1296795A (en) Methods for preventing or treating hiv-1 or hiv-2 infection